• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亮氨酸重复激酶2(LRRK2)调节秀丽隐杆线虫对线粒体功能障碍的易感性。

LRRK2 modulates vulnerability to mitochondrial dysfunction in Caenorhabditis elegans.

作者信息

Saha Shamol, Guillily Maria D, Ferree Andrew, Lanceta Joel, Chan Diane, Ghosh Joy, Hsu Cindy H, Segal Lilach, Raghavan Kesav, Matsumoto Kunihiro, Hisamoto Naoki, Kuwahara Tomoki, Iwatsubo Takeshi, Moore Landon, Goldstein Lee, Cookson Mark, Wolozin Benjamin

机构信息

Department of Pharmacology, Boston University School of Medicine, Boston, Massachusetts 02118, USA.

出版信息

J Neurosci. 2009 Jul 22;29(29):9210-8. doi: 10.1523/JNEUROSCI.2281-09.2009.

DOI:10.1523/JNEUROSCI.2281-09.2009
PMID:19625511
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3127548/
Abstract

Mutations in leucine-rich repeat kinase 2 (LRRK2) cause autosomal-dominant familial Parkinson's disease. We generated lines of Caenorhabditis elegans expressing neuronally directed human LRRK2. Expressing human LRRK2 increased nematode survival in response to rotenone or paraquat, which are agents that cause mitochondrial dysfunction. Protection by G2019S, R1441C, or kinase-dead LRRK2 was less than protection by wild-type LRRK2. Knockdown of lrk-1, the endogenous ortholog of LRRK2 in C. elegans, reduced survival associated with mitochondrial dysfunction. C. elegans expressing LRRK2 showed rapid loss of dopaminergic markers (DAT::GFP fluorescence and dopamine levels) beginning in early adulthood. Loss of dopaminergic markers was greater for the G2019S LRRK2 line than for the wild-type line. Rotenone treatment induced a larger loss of dopamine markers in C. elegans expressing G2019S LRRK2 than in C. elegans expressing wild-type LRRK2; however, loss of dopaminergic markers in the G2019S LRRK2 nematode lines was not statistically different from that in the control line. These data suggest that LRRK2 plays an important role in modulating the response to mitochondrial inhibition and raises the possibility that mutations in LRRK2 selectively enhance the vulnerability of dopaminergic neurons to a stressor associated with Parkinson's disease.

摘要

富含亮氨酸重复激酶2(LRRK2)的突变会导致常染色体显性遗传性帕金森病。我们构建了表达神经元定向人类LRRK2的秀丽隐杆线虫品系。表达人类LRRK2可提高线虫对鱼藤酮或百草枯的存活率,这两种物质会导致线粒体功能障碍。G2019S、R1441C或激酶失活的LRRK2提供的保护作用小于野生型LRRK2。敲低线虫中LRRK2的内源性直系同源基因lrk-1,会降低与线粒体功能障碍相关的存活率。表达LRRK2的秀丽隐杆线虫从成年早期开始就出现多巴胺能标记物(多巴胺转运体::绿色荧光蛋白荧光和多巴胺水平)的快速丧失。G2019S LRRK2品系中多巴胺能标记物的丧失比野生型品系更严重。鱼藤酮处理使表达G2019S LRRK2的秀丽隐杆线虫中多巴胺标记物的丧失比表达野生型LRRK2的线虫更大;然而,G2019S LRRK2线虫品系中多巴胺能标记物的丧失与对照品系相比无统计学差异。这些数据表明,LRRK2在调节对线粒体抑制的反应中起重要作用,并增加了LRRK2突变选择性增强多巴胺能神经元对与帕金森病相关应激源易感性的可能性。

相似文献

1
LRRK2 modulates vulnerability to mitochondrial dysfunction in Caenorhabditis elegans.亮氨酸重复激酶2(LRRK2)调节秀丽隐杆线虫对线粒体功能障碍的易感性。
J Neurosci. 2009 Jul 22;29(29):9210-8. doi: 10.1523/JNEUROSCI.2281-09.2009.
2
LRRK2-mediated neurodegeneration and dysfunction of dopaminergic neurons in a Caenorhabditis elegans model of Parkinson's disease.LRRK2 介导的帕金森病线虫模型中多巴胺能神经元的神经退行性变和功能障碍。
Neurobiol Dis. 2010 Oct;40(1):73-81. doi: 10.1016/j.nbd.2010.04.002. Epub 2010 Apr 9.
3
Investigating convergent actions of genes linked to familial Parkinson's disease.研究与家族性帕金森病相关基因的协同作用。
Neurodegener Dis. 2008;5(3-4):182-5. doi: 10.1159/000113697. Epub 2008 Mar 6.
4
MKK6 binds and regulates expression of Parkinson's disease-related protein LRRK2.MKK6 结合并调节帕金森病相关蛋白 LRRK2 的表达。
J Neurochem. 2010 Mar;112(6):1593-604. doi: 10.1111/j.1471-4159.2010.06568.x. Epub 2010 Jan 7.
5
Kinase inhibitors arrest neurodegeneration in cell and C. elegans models of LRRK2 toxicity.激酶抑制剂可阻止 LRRK2 毒性的细胞和秀丽隐杆线虫模型中的神经退行性变。
Hum Mol Genet. 2013 Jan 15;22(2):328-44. doi: 10.1093/hmg/dds431. Epub 2012 Oct 12.
6
Selective expression of Parkinson's disease-related Leucine-rich repeat kinase 2 G2019S missense mutation in midbrain dopaminergic neurons impairs dopamine release and dopaminergic gene expression.帕金森病相关的富含亮氨酸重复激酶2 G2019S错义突变在中脑多巴胺能神经元中的选择性表达会损害多巴胺释放及多巴胺能基因表达。
Hum Mol Genet. 2015 Sep 15;24(18):5299-312. doi: 10.1093/hmg/ddv249. Epub 2015 Jun 29.
7
LRRK2 kinase inhibition protects against Parkinson's disease-associated environmental toxicants.LRRK2 激酶抑制可预防帕金森病相关环境毒物。
Neurobiol Dis. 2024 Jun 15;196:106522. doi: 10.1016/j.nbd.2024.106522. Epub 2024 May 3.
8
Redox proteomics analyses of the influence of co-expression of wild-type or mutated LRRK2 and Tau on C. elegans protein expression and oxidative modification: relevance to Parkinson disease.氧化还原蛋白质组学分析共表达野生型或突变型 LRRK2 和 Tau 对秀丽隐杆线虫蛋白质表达和氧化修饰的影响:与帕金森病的相关性。
Antioxid Redox Signal. 2012 Dec 1;17(11):1490-506. doi: 10.1089/ars.2011.4312. Epub 2012 Mar 20.
9
Dopamine D2 receptor-mediated neuroprotection in a G2019S Lrrk2 genetic model of Parkinson's disease.多巴胺 D2 受体介导的帕金森病 G2019S Lrrk2 基因突变模型中的神经保护作用。
Cell Death Dis. 2018 Feb 12;9(2):204. doi: 10.1038/s41419-017-0221-2.
10
The Human LRRK2 Modulates the Age-Dependent Effects of Developmental Methylmercury Exposure in Caenorhabditis elegans.人类 LRRK2 调节秀丽隐杆线虫中发育性甲基汞暴露的年龄依赖性效应。
Neurotox Res. 2022 Oct;40(5):1235-1247. doi: 10.1007/s12640-022-00547-x. Epub 2022 Jul 15.

引用本文的文献

1
Parkinson Disease Signaling Pathways, Molecular Mechanisms, and Potential Therapeutic Strategies: A Comprehensive Review.帕金森病信号通路、分子机制及潜在治疗策略:综述
Int J Mol Sci. 2025 Jul 3;26(13):6416. doi: 10.3390/ijms26136416.
2
Studying the mechanisms of neurodegeneration: advantages and opportunities.研究神经退行性变的机制:优势与机遇。
Front Cell Neurosci. 2025 Mar 26;19:1559151. doi: 10.3389/fncel.2025.1559151. eCollection 2025.
3
Modeling of Parkinson's Disease in Different Models.不同模型中帕金森病的建模
CNS Neurol Disord Drug Targets. 2025;24(2):102-114. doi: 10.2174/0118715273326866240922193029.
4
Novel C. elegans models of Lewy body disease reveal pathological protein interactions and widespread miRNA dysregulation.新型秀丽隐杆线虫路易体病模型揭示了病理性蛋白相互作用和广泛的 miRNA 失调。
Cell Mol Life Sci. 2024 Aug 30;81(1):377. doi: 10.1007/s00018-024-05383-0.
5
Towards improved screening of toxins for Parkinson's risk.致力于改进帕金森病风险毒素筛查。
NPJ Parkinsons Dis. 2023 Dec 19;9(1):169. doi: 10.1038/s41531-023-00615-9.
6
Animal models of Parkinson's disease: bridging the gap between disease hallmarks and research questions.帕金森病动物模型:弥合疾病特征与研究问题之间的差距。
Transl Neurodegener. 2023 Jul 19;12(1):36. doi: 10.1186/s40035-023-00368-8.
7
as a Model System to Study Human Neurodegenerative Disorders.作为研究人类神经退行性疾病的模型系统。
Biomolecules. 2023 Mar 5;13(3):478. doi: 10.3390/biom13030478.
8
Is Disrupted Mitophagy a Central Player to Parkinson's Disease Pathology?线粒体自噬功能紊乱是帕金森病病理的核心因素吗?
Cureus. 2023 Feb 25;15(2):e35458. doi: 10.7759/cureus.35458. eCollection 2023 Feb.
9
Signaling pathways in Parkinson's disease: molecular mechanisms and therapeutic interventions.帕金森病中的信号通路:分子机制与治疗干预。
Signal Transduct Target Ther. 2023 Feb 21;8(1):73. doi: 10.1038/s41392-023-01353-3.
10
Human Induced Pluripotent Stem Cell Phenotyping and Preclinical Modeling of Familial Parkinson's Disease.人类诱导多能干细胞表型分析及家族性帕金森病的临床前建模。
Genes (Basel). 2022 Oct 25;13(11):1937. doi: 10.3390/genes13111937.

本文引用的文献

1
Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson's disease.突变型LRRK2(R1441G)细菌人工染色体转基因小鼠重现了帕金森病的主要特征。
Nat Neurosci. 2009 Jul;12(7):826-8. doi: 10.1038/nn.2349. Epub 2009 Jun 7.
2
Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons.胞质多巴胺、钙和α-突触核蛋白之间的相互作用导致黑质神经元选择性死亡。
Neuron. 2009 Apr 30;62(2):218-29. doi: 10.1016/j.neuron.2009.01.033.
3
Parkin protects dopaminergic neurons against microtubule-depolymerizing toxins by attenuating microtubule-associated protein kinase activation.帕金蛋白通过减弱微管相关蛋白激酶的激活来保护多巴胺能神经元免受微管解聚毒素的侵害。
J Biol Chem. 2009 Feb 6;284(6):4009-17. doi: 10.1074/jbc.M806245200. Epub 2008 Dec 11.
4
Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila.LRRK2对4E-BP的磷酸化作用影响果蝇中多巴胺能神经元的维持。
EMBO J. 2008 Sep 17;27(18):2432-43. doi: 10.1038/emboj.2008.163. Epub 2008 Aug 14.
5
Hypothesis-based RNAi screening identifies neuroprotective genes in a Parkinson's disease model.基于假设的RNA干扰筛选在帕金森病模型中鉴定出神经保护基因。
Proc Natl Acad Sci U S A. 2008 Jan 15;105(2):728-33. doi: 10.1073/pnas.0711018105. Epub 2008 Jan 8.
6
The Parkinson's disease protein alpha-synuclein disrupts cellular Rab homeostasis.帕金森病蛋白α-突触核蛋白破坏细胞Rab蛋白稳态。
Proc Natl Acad Sci U S A. 2008 Jan 8;105(1):145-50. doi: 10.1073/pnas.0710685105. Epub 2007 Dec 27.
7
RNA interference of LRRK2-microarray expression analysis of a Parkinson's disease key player.帕金森病关键因子LRRK2的RNA干扰-微阵列表达分析
Neurogenetics. 2008 May;9(2):83-94. doi: 10.1007/s10048-007-0114-0. Epub 2007 Dec 21.
8
Mitochondria in the aetiology and pathogenesis of Parkinson's disease.线粒体在帕金森病的病因学和发病机制中的作用
Lancet Neurol. 2008 Jan;7(1):97-109. doi: 10.1016/S1474-4422(07)70327-7.
9
Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin.人类PINK1功能丧失会导致线粒体病变,而帕金森蛋白可挽救这种情况。
J Neurosci. 2007 Nov 7;27(45):12413-8. doi: 10.1523/JNEUROSCI.0719-07.2007.
10
The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1.线粒体蛋白酶HtrA2受帕金森病相关激酶PINK1的调控。
Nat Cell Biol. 2007 Nov;9(11):1243-52. doi: 10.1038/ncb1644. Epub 2007 Sep 30.